Intel Capital invests in dental AI company Retrace

By DrBicuspid Staff

May 20, 2020 -- Intel Capital has invested $132 million in 11 technology startups, including dental artificial intelligence (AI) company Retrace.

San Francisco-based Retrace uses dental data to reduce the oral disease burden. It uses AI and other technologies in its predictive analytics platform to improve dental decision-making, according to the company.

Intel also invested in Anodot, Astera Labs, Axonne, Hypersonix, KFBIO, Lilt, MemVerge, ProPlus Electronics, Spectrum Materials, and Xsight Labs.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking